You are on page 1of 1

Controlling

Protein Found to Cause Low-


Oxygen Induced Metastasis Metastatic
Cancer
by Jennifer Huang

T
he majority of cancer deaths occur when cancer cells a circular or regular structure. However, hypoxic cells
spread from a localized tumor to other parts of the with high Lox expression display extensive branching. The
body during a process called metastasis. Investigations formation of these cellular projections may facilitate the
into the mechanisms of metastasis have revealed that a migration and metastasis of cancerous tumors.
low-oxygen micro-environment - hypoxia - within the tumor can
contribute to this lethal process. Dr. Janine Erler and Dr. Amato Metastatic Model
Giaccia at the Stanford University School of Medicine found that The Lox-expressing cancer cells and the Lox-inhibited
a protein called lysyl oxidase (Lox) is related to high metastasis cancer cells grew at similar rates when injected into orthotopic
rates and low-oxygen micro-environments in breast, head and tissues in mice (tissues that are of the same type and location
neck cancers. as that of the origin of the cancer cells). However, only the
Lox is a protein that regulates the development of Lox-expressing cancer cells were able to grow when injected
connective tissue in the extracellular matrix. A previous into mice tissue of different origin than the tissue from
study demonstrated that the expression of Lox protein is which the cancer cells originated. This implies that elevated
significantly higher in hypoxic environments. By analyzing Lox levels are implicated in tumor metastasis, since the Lox-
tumors in patients with breast, head or neck cancers, Erler inhibited cells were unable to proliferate when the metastatic
confirmed this relationship, showing that Lox is regulated pathway was artificially bypassed.
by a hypoxia-inducible Erler predicted that Lox inhibition could work effectively
factor. Her results against a wide range of cancers, including difficult to treat
also provided evidence and aggressively lethal metastatic cancers. For patients
that high expression with such cancers, Lox inhibition could become a treatment
of the Lox protein option.
significantly lowers a
patient’s survival. Challenges facing Lox inhibition treatments
An experimental Despite the promise of Lox inhibition treatments, there
model of Lox expression are several obstacles to overcome. First, Lox expression is
was developed to further present both intracellularly and extracellularly, and only the
examine its impact extracellular expression should be reduced. The tampering
on tumor metastasis. of intracellular Lox expression may increase the risk of cancer
Researchers engineered development. More research is thus required to determine
human breast and how to specifically target extracellular Lox. Second, further
cervical cancer cells pre-clinical testing must be performed to confirm the results
that expressed lower before human trials can begin. The first clinical studies
levels of Lox. These will likely be expensive, costing around $10 million. Erler
Dr. Janine Erler is studying how cells die cells were injected into hopes to see human trials take place within five years, as this
through metastasis.
mice, and the lower method may be a promising way to treat many of the most
levels of Lox expression were verified experimentally. When aggressive and dangerous metastatic cancers. S
comparing these tumors with those in mice with an elevated
Lox expression profile, it was found that mice injected with JENNIFER HUANG is a freshman majoring in the biological sciences
cells of lower Lox expression had at least five- to ten-fold and hopes to pursue a career in medicine and/or research. She
fewer metastatic tumors. enjoys rock climbing, hiking, and fencing and loves jigsaw puzzles
Erler also used the Lox expression model to study cell and word games.
motility. The cells engineered to express low levels of Lox To Learn More:
displayed a reduction in cell movement, migration, and
cell invasion--the first step in tumor metastasis. This can Read Erler, J. T. et al. Lysyl oxidase is essential for hypoxia-
be explained because the structure of a cell is critical to its induced metastasis. Nature 440. 27. 1222-1226 (2006)
movement. A normal, non-motile cell typically maintains

layout design: volume v 17

You might also like